Table 3.
Viral test for COVID-19
| Sources | Technology |
Molecule Tested |
Sample Site |
Time to Get results |
Principle | Advantages | Limitations |
Specificity/ Sensitivity |
|---|---|---|---|---|---|---|---|---|
| Alcoba-Florez et al (2020) [131] | Real-Time PCR(RT-PCR) | Viral RNA | Nasopharyngeal swab, sputum, stool | 3–4 hrs | Nucleic acid amplification test | - Gold standard diagnostic test. - Identifies directly the presence of virus. |
Sensitive to sample collection error. Labor intensive. Specialized high-cost equipment. |
>97%/>95% |
| Peto et al (2020) [132] | LAMP | Viral RNA | Nasopharyngeal swab, sputum, stool | 2–3 hrs | Nucleic acid amplification test | - Cost-efficient. - Can be read by eye. |
New techniques still under clinical investigation | >95% |
| Lisboa et al (2020) [133] | ELISA | IgG or IgM | Blood | 1–3 hrs | Detection of IgM/IgG ot RBD IgG antibodies, via colorimetric assay | - Cost-effective. - Well documented in science. - Test 96 samples at a time. |
Requires laboratory. Not well- established for SARS-CoV-2 |
79%/80% |
| Nicol et al (2020) [134] | Lateral Flow Immunoassays | IgG or IgM | Blood | 15 to 20 min | Detection of IgM/IgG antibodies via color change of strip in lateral flow assay |
- Extremely quick results. - Little training required. |
- Evidence for accuracy still under investigation. - Expensive. - Not effective for large batch testing |
96%/80% |